11Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, which often leads to the emergence of resistant organisms. Achromobacter xylosoxidans is a new emergent pathogen in CF spectrum. From 2005 to 2010 we had an outbreak in A. xylosoxidans prevalence in our CF center, thus, the present study was aimed at deeply investigating virulence traits of A. xylosoxidans strains isolated from infected CF patients. To this purpose, we assessed A. xylosoxidansgenome variability by randomly amplified polymorphic DNA (RAPD), biofilm production, antibiotic resistances, and motility. All A. xylosoxidans strains resulted to be biofilm producers, and were resistant to antibiotics usually employed in CF treatment. H...
Recent reports document an increasing incidence of new Gram-negative pathogens such as Stenotrophomo...
Achromobacter spp. are recognized as emerging pathogens in hospitalized as well as in cystic fibrosi...
International audienceIn patients with cystic fibrosis (CF), the lung is a remarkable ecological nic...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
Bacterial pathogens evolve during chronic colonization of the human host by selection for pathoadapt...
9Achromobacter xylosoxidans is an emerging pathogen increasingly being isolated from respiratory sam...
Pulmonary infections by Gram-negative bacteria such as Achromobacter xylosoxidans are recovered freq...
The aims of this study were to evaluate the frequency of Achromobacter xylosoxidans infection in a c...
International audienceBacteria of the genus Achromobacter are environmental germs, with an unknown r...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
AbstractBackgroundAchromobacter xylosoxidans is increasingly cultured in sputum from cystic fibrosis...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
Achromobacter xylosoxidans is an aerobic nonfermentative Gram-Negative rod considered as an importan...
Background: Achromobacter xylosoxidans is increasingly being recognized as an emerging pathogen in c...
Recent reports document an increasing incidence of new Gram-negative pathogens such as Stenotrophomo...
Achromobacter spp. are recognized as emerging pathogens in hospitalized as well as in cystic fibrosi...
International audienceIn patients with cystic fibrosis (CF), the lung is a remarkable ecological nic...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
Bacterial pathogens evolve during chronic colonization of the human host by selection for pathoadapt...
9Achromobacter xylosoxidans is an emerging pathogen increasingly being isolated from respiratory sam...
Pulmonary infections by Gram-negative bacteria such as Achromobacter xylosoxidans are recovered freq...
The aims of this study were to evaluate the frequency of Achromobacter xylosoxidans infection in a c...
International audienceBacteria of the genus Achromobacter are environmental germs, with an unknown r...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
AbstractBackgroundAchromobacter xylosoxidans is increasingly cultured in sputum from cystic fibrosis...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
Achromobacter xylosoxidans is an aerobic nonfermentative Gram-Negative rod considered as an importan...
Background: Achromobacter xylosoxidans is increasingly being recognized as an emerging pathogen in c...
Recent reports document an increasing incidence of new Gram-negative pathogens such as Stenotrophomo...
Achromobacter spp. are recognized as emerging pathogens in hospitalized as well as in cystic fibrosi...
International audienceIn patients with cystic fibrosis (CF), the lung is a remarkable ecological nic...